CSL Ltd – Strategy, SWOT and Corporate Finance Report
- Pages: 50
- Published: October 2019
- Report Code: MLPH66579FSA
CSL Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
CSL Ltd (CSL) discovers, develops, manufactures, commercializes, and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and secondary immune deficiencies, inherited respiratory disease and neurological disorders; influenza vaccine; and protein-based medicines for treating serious human illnesses. The company also provides products for the prevention of hemolytic disease in newborns and infection in solid organ transplant recipients and to treat specific infections and help victims of trauma, shock and burns. CSL also markets an array of vaccines, anti-venoms, and pharmaceutical products of various other manufacturers. The company sells its products in Australia, Germany, Switzerland, the UK, the US and rest of the world. CSL is headquartered in Parkville, Victoria, Australia.
Scope
Detailed information on CSL Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting CSL Ltd in the form of a SWOT analysis
An in-depth view of the business model of CSL Ltd including a breakdown and examination of key business segments
News about CSL Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of CSL Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess CSL Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on CSL Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Plasvacc Pty Ltd
Novita Healthcare Ltd
Novavax Inc
Merck & Co Inc
MedImmune LLC
GlaxoSmithKline Plc
Daiichi Sankyo Co Ltd
AstraZeneca Plc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.